<DOC>
	<DOCNO>NCT01434576</DOCNO>
	<brief_summary>The purpose study evaluate pharmacodynamics , safety , pharmacokinetics HGS1025 patient moderate severe ulcerative colitis .</brief_summary>
	<brief_title>Study Evaluate Pharmacodynamics Safety HGS1025 Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Adults least 18 year age Active , moderate severe ulcerative colitis ( UC ) confirm endoscopy Currently 1 follow UC treatment medication : 5aminosalicylates ( 5ASA ) , corticosteroid , azathioprine , 6mercaptopurine ( 6MP ) , and/or immunosuppressive immunomodulatory agent include cyclosporine , tacrolimus , methotrexate , mycophenolic acid Not pregnant nursing Females nonchildbearing potential female childbearing potential must willing practice abstinence intercourse 2 week prior first dose study agent 8 week last dose study agent use effective contraception 1 month prior 1st dose study agent 8 week last dose study agent Males must agree use effective contraception throughout study 8 week last dose study agent Have ability provide inform consent comply study procedure Received follow within 60 day first dose study agent : AntiTNFÎ± therapy ; integrin receptor antagonist ; intravenous immunoglobulin ; high dose prednisone prednisone equivalent ( great 60 mg/day ) ; investigational agent include immunosuppressive/immunomodulatory nonbiologic agent Have change corticosteroid , 5ASA , immunosuppressive/immunomodulatory agent within 30 day Day 0 History liver disease History major organ transplant History prior large bowel resection Current unstable uncontrolled acute chronic disease due UC History malignant neoplasm within last 5 year , except type adequately treat cancer skin carcinoma situ uterine cervix Current recent drug alcohol abuse dependence History positive test HIV test positive Hepatitis B ( HBsAg ) Hepatitis C Have history severe drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>